Banco Santander, S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

A detailed history of Banco Santander, S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Banco Santander, S.A. holds 7,698 shares of REGN stock, worth $5.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

7,698

Previous 7,571 1.68%

Holding current value

$5.4 Million

Previous $7.96 Million 1.7%

% of portfolio

0.1%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $130,059 - $152,623	127 Added 1.68%	7,698 $8.09 Million
Q2 2024 Jul 29, 2024	BUY	$883.2 - $1071.19 $111,283 - $134,969	126 Added 1.69%	7,571 $7.96 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $865,679 - $952,622	-959 Reduced 11.41%	7,445 $7.17 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $524,796 - $596,910	-677 Reduced 7.46%	8,404 $7.38 Million
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $311,602 - $379,966	-450 Reduced 4.72%	9,081 $7.47 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $1.45 Million - $1.72 Million	-2,070 Reduced 17.84%	9,531 $6.85 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $741,053 - $900,570	-1,089 Reduced 8.58%	11,601 $9.53 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $2.88 Million - $3.13 Million	-4,084 Reduced 24.35%	12,690 $9.16 Million
Q3 2022 Nov 08, 2022	SELL	$573.97 - $724.32 $55,101 - $69,534	-96 Reduced 0.57%	16,774 $11.6 Million
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $2.14 Million - $2.88 Million	-3,900 Reduced 18.78%	16,870 $9.97 Million
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $1.41 Million - $1.66 Million	2,370 Added 12.88%	20,770 $14.5 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $1.37 Million - $1.69 Million	2,514 Added 15.83%	18,400 $11.6 Million
Q3 2021 Nov 08, 2021	SELL	$574.03 - $680.96 $1.6 Million - $1.9 Million	-2,791 Reduced 14.94%	15,886 $9.61 Million
Q2 2021 Jul 29, 2021	BUY	$472.8 - $558.54 $343,725 - $406,058	727 Added 4.05%	18,677 $10.4 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $2.26 Million - $2.78 Million	5,063 Added 39.29%	17,950 $8.49 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1.14 Million - $1.45 Million	2,378 Added 22.63%	12,887 $6.23 Million
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $1.41 Million - $1.71 Million	2,593 Added 32.76%	10,509 $5.88 Million
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $986 - $1,287	2 Added 0.03%	7,916 $4.94 Million
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $172,796 - $254,137	514 Added 6.95%	7,914 $3.86 Million
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $13,706 - $18,825	50 Added 0.68%	7,400 $2.78 Million
Q3 2019 Nov 06, 2019	SELL	$273.46 - $318.39 $738,342 - $859,653	-2,700 Reduced 26.87%	7,350 $2.05 Million
Q2 2019 Aug 07, 2019	BUY	$299.6 - $414.82 $1 Million - $1.39 Million	3,350 Added 50.0%	10,050 $3.14 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $744,160 - $879,140	2,000 Added 42.55%	6,700 $2.72 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $4.25 Million - $4.94 Million	-12,100 Reduced 72.02%	4,700 $1.9 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $4.78 Million - $5.8 Million	16,800 New	16,800 $5.8 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Regeneron Pharmaceuticals, Inc. Transaction History